Our mission is to advance our portfolio to clinical trials and improve the lives of those affected by neurovascular ophthalmic pathologies.
Retinset is a clinical-stage spin out from MEDICAL MIX with a purpose on providing new treatments in retinal pathologies. We have developed an innovative delivery solution to take drugs to the retina. Our leading program (BSL01) is a first-in-class eye drop formulation to treat Diabetic Retinopathy (DR) since very early stages. We have successfully completed a Phase I Clinical Trial.